-
ICD-10-CM Codes
›
-
C00-D49
›
-
D37-D48
›
-
D47-
›
-
2023 ICD-10-CM Diagnosis Code D47.9
2023 ICD-10-CM Diagnosis Code D47.9
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- D47.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Neoplm of uncrt behav of lymphoid,hematpoetc & rel tiss,unsp
- The 2023 edition of ICD-10-CM D47.9 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D47.9 - other international versions of ICD-10 D47.9 may differ.
Applicable To- Lymphoproliferative disease NOS
The following code(s) above
D47.9 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D47.9:
Approximate Synonyms
- Hemolytic anemia associated with lymphoproliferative disorder
- Hemolytic anemia, lymphoproliferative disease
- Lymphoproliferative disorder
Clinical Information
- A disease in which cells of the lymphatic system grow excessively. Lymphoproliferative disorders are often treated like cancer.
- A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).
- Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
ICD-10-CM D47.9 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Convert D47.9 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To D47.9
D47.09 Other mast cell neoplasms of uncertain behavior
D47.1 Chronic myeloproliferative disease
D47.2 Monoclonal gammopathy
D47.3 Essential (hemorrhagic) thrombocythemia
D47.Z Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
D47.Z1 Post-transplant lymphoproliferative disorder (PTLD)
D47.Z9 Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
D47.9
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
D48 Neoplasm of uncertain behavior of other and unspecified sites
D48.0 Neoplasm of uncertain behavior of bone and articular cartilage
D48.1 Neoplasm of uncertain behavior of connective and other soft tissue
D48.2 Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system
D48.3 Neoplasm of uncertain behavior of retroperitoneum
D48.4 Neoplasm of uncertain behavior of peritoneum
D48.5 Neoplasm of uncertain behavior of skin
D48.6 Neoplasm of uncertain behavior of breast
D48.60 Neoplasm of uncertain behavior of unspecified breast
D48.61 Neoplasm of uncertain behavior of right breast
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.